Additionally, similar concentration-dependent protein ligand binding kinetics have been reported in the literature.
It should be noted that time dependent inhibitory phenomena had been observed in previous studies of HDAC inhibitors, and three factors contributing to such time-dependent binding kinetics have been proposed: (A) the ligand exchange, (B) the hydrogen-bond rearrangement, and (C) the local-conformation change.
In recent years, the importance of binding kinetics has been increasingly recognized and appreciated in drug discovery by many groups.
The effects of alanine-scanning mutations in α-H and α-I on polymerase activity, primer/template (P/T) binding, fidelity and enzyme kinetics have been determined.
The study on the binding kinetics have shown that the dissociation constant (Kd) and the binding valency for the sensor in B. anthracis spores solutions are 193 cfu/ml and 2.32.
Thus, the binding kinetics has proven to be more rapid than previously believed.
8 For the last decade, the concept of drug‐target residence time or binding kinetics (BKs) has been in focus in the drug discovery and development literature, 9 because there is mounting evidence that the often ignored kinetic aspects of the interaction between a small molecule drug and its protein target in the body are highly relevant for in vivo efficacy and clinical success.
For example, the ligand binding and gating kinetics of acetylcholine receptors have been well characterized with single-channel recordings (Purohit et al., 2007; Grosman et al., 2000).
Substrate binding and rebinding kinetics after photolysis of myoglobin have been intensively studied, e.g. by X-ray crystallography [ 2, 3], time-resolved UV/Vis spectroscopy [ 4, 5] and time-resolved infrared spectroscopy [ 6, 7].
However, no growth kinetics and activity data have been provided.
Bevacizumab (BVZ), a humanized monoclonal antibody against vascular epithelial growth factor (vegf), alters the kinetics of ligand binding and has been shown to abrogate angiogenesis in different types of solid tumors [ 2].
